ZyVersa Therapeutics (NASDAQ:ZVSA) just reported results for the second quarter of 2024.
- ZyVersa Therapeutics reported earnings per share of -$3.31. This was above the analyst estimate for EPS of -$3.75.
- The company did not report any revenue for the quarter.